- Home
- DYN vs IAS Comparison
DYN vs IAS Comparison
Compare DYN & IAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- IAS
- Stock Information
- Founded
- DYN 1984
- IAS 2009
- Country
- DYN United States
- IAS United States
- Employees
- DYN N/A
- IAS N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- IAS Computer Software: Programming Data Processing
- Sector
- DYN Health Care
- IAS Technology
- Exchange
- DYN Nasdaq
- IAS Nasdaq
- Market Cap
- DYN 1.4B
- IAS 1.4B
- IPO Year
- DYN 2020
- IAS 2021
- Fundamental
- Price
- DYN $12.50
- IAS $9.03
- Analyst Decision
- DYN Strong Buy
- IAS Buy
- Analyst Count
- DYN 15
- IAS 11
- Target Price
- DYN $36.00
- IAS $13.55
- AVG Volume (30 Days)
- DYN 3.0M
- IAS 903.7K
- Earning Date
- DYN 07-28-2025
- IAS 08-07-2025
- Dividend Yield
- DYN N/A
- IAS N/A
- EPS Growth
- DYN N/A
- IAS 3014.55
- EPS
- DYN N/A
- IAS 0.34
- Revenue
- DYN N/A
- IAS $569,836,000.00
- Revenue This Year
- DYN N/A
- IAS $13.39
- Revenue Next Year
- DYN N/A
- IAS $11.45
- P/E Ratio
- DYN N/A
- IAS $26.66
- Revenue Growth
- DYN N/A
- IAS 14.39
- 52 Week Low
- DYN $6.36
- IAS $6.26
- 52 Week High
- DYN $47.45
- IAS $13.62
- Technical
- Relative Strength Index (RSI)
- DYN 70.49
- IAS 64.87
- Support Level
- DYN $10.78
- IAS $8.61
- Resistance Level
- DYN $12.59
- IAS $9.13
- Average True Range (ATR)
- DYN 0.82
- IAS 0.31
- MACD
- DYN 0.31
- IAS 0.10
- Stochastic Oscillator
- DYN 78.35
- IAS 93.12
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About IAS Integral Ad Science Holding Corp.
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.